Skip to main content
. Author manuscript; available in PMC: 2018 Dec 12.
Published in final edited form as: Obesity (Silver Spring). 2018 Jun 12;26(7):1179–1187. doi: 10.1002/oby.22213

Table 2.

Mixed-muscle protein and muscle mitochondrial protein d9-leucine enrichment

Biopsy time
120 min 300 min 540 min
Mixed-muscle protein (MPE)
 Lean subjects 0.007 ± 0.001 0.017 ± 0.001# 0.034 ± 0.002&
 Subjects with obesity 0.006 ± 0.001 0.014 ± 0.001# 0.034 ± 0.004&
Mitochondrial protein (MPE)
 Lean subjects 0.011 ± 0.001 0.023 ± 0.001# 0.045 ± 0.004&
 Subjects with obesity 0.010 ± 0.001 0.019 ± 0.001# 0.042 ± 0.002&

Values represent the mean ± SEM. Biopsy time reflects the time after the start of leucine tracer infusion (see text); 120 and 300 min correspond to fasted-state plasma amino acid concentrations, whereas 540 min corresponds to elevated plasma amino acid concentrations; MPE, molar percent excess. There were significant time (P ≤ 0.05) but not group (P > 0.05) main effects for both mixed-muscle and mitochondrial proteins.

#

P ≤ 0.05 versus 120 min;

&

P ≤ 0.05 versus both 120 and 300 min.